Thermo Scientific™ CaptureSelect™ IgA-XL Affinity Matrix is intended for the purification of human IgA, with no binding to other immunoglobulins.
CaptureSelect IgA-XL Affinity Matrix is intended for the purification of human IgA, with no binding to other immunoglobulins. The IgA-XL affinity matrix provides improved binding capacities (>15 g/L IgA) and elution characteristics (full elution at pH 4) compared to CaptureSelect IgA Affinity Matrix.
Features of this affinity matrix include:
CaptureSelect IgA-XL Affinity Matrix binds to the Fc part of IgA. The high selectivity and yields obtained using IgA-XL Affinity Matrix enable a robust, fast, and efficient purification process with excellent purity obtained in one step.
CaptureSelect products contain affinity ligands based on recombinant single-domain antibody fragments (VHH) created by a proprietary technology. The VHH affinity ligand is a 12–15 kDa fragment comprising the three complementarity-determining regions (CDRs) that form the antigen-binding domain, efficiently produced in the yeast Saccharomyces cerevisiae by a production process free of any animal components (animal origin-free).
| Marque | Thermo Scientific |
|---|---|
| Réf. B-LABO | BL-RE-168697 |
| Réf. fabricant | 30245090 |
| Débit | 50–200 cm/hr. (up to 2 bar) |
| Formule | 20% (v/v) ethanol |
| Contenu et stockage | Store at 2–8°C. Protect from direct sunlight. |
| Granulométrie | 65 ±10 μm |
| Forme | Resin Slurry |
| Gamme de produits | CaptureSelect™ |
| Quantité | 5 mL |
| À utiliser avec (application) | Purification of all IgA subtypes (IgA1, IgA2, dimeric IgA, secretory IgA) |
| Cible | IgA-Fc domain |
| Type | Affinity Matrix |
| Type de ligand | CaptureSelect IgA-XL Affinity Ligand |
